At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's ...
October 12, 2022 — Following the recent European Society of Cardiology (ESC) Congress in Barcelona, Spain last month ...
October 12, 2022 — Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 12, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG ...
Change Healthcare’s cloud-native archiving, viewing, and image-sharing solutions can help improve efficiencies in ...
October 11, 2022 — The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 11, 2022 — Researchers from the University of Minnesota Medical School found that patients with certain features ...
October 11, 2022 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it has ...
October 7, 2022 — A new research grant will enable University of Cincinnati researchers to learn more about how ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 7, 2022 — Ultromics, a digital health technology company pioneering the development of transformative heart ...
October 7, 2022 — ChromaDex Corp. announced promising findings from a clinical study, as reported in the peer-reviewed ...
October 6, 2022 — The complications experienced by heart failure patients implanted with a left ventricular assist ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 6, 2022 — Stroke is the leading cause of age-related motor disabilities and is becoming more prevalent in ...
October 6, 2022 – OpSens Inc., a Quebec-based medical device cardiology-focused company, has announced that it has ...
At TCT 2022, Dr. Akl Fahed, Physician-scientist and Interventional Cardiologist, Massachusetts General Hospital and ...